FI116931B - Menetelmä farmaseuttisen tai eläinlääketieteellisen koostumuksen valmistamiseksi - Google Patents

Menetelmä farmaseuttisen tai eläinlääketieteellisen koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI116931B
FI116931B FI961720A FI961720A FI116931B FI 116931 B FI116931 B FI 116931B FI 961720 A FI961720 A FI 961720A FI 961720 A FI961720 A FI 961720A FI 116931 B FI116931 B FI 116931B
Authority
FI
Finland
Prior art keywords
weight
composition
preparation
pharmaceutical
ester
Prior art date
Application number
FI961720A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961720A (fi
FI961720A0 (fi
Inventor
Harvey Lee Zimmerman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303736&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI116931(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321876A external-priority patent/GB9321876D0/en
Priority claimed from GB939322288A external-priority patent/GB9322288D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of FI961720A publication Critical patent/FI961720A/fi
Publication of FI961720A0 publication Critical patent/FI961720A0/fi
Application granted granted Critical
Publication of FI116931B publication Critical patent/FI116931B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI961720A 1993-10-22 1996-04-19 Menetelmä farmaseuttisen tai eläinlääketieteellisen koostumuksen valmistamiseksi FI116931B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9321876 1993-10-22
GB939321876A GB9321876D0 (en) 1993-10-22 1993-10-22 Novel composition
GB939322288A GB9322288D0 (en) 1993-10-29 1993-10-29 Novel composition
GB9322288 1993-10-29
PCT/US1994/012026 WO1995010999A1 (fr) 1993-10-22 1994-10-20 Nouvelle composition
US9412026 1994-10-20

Publications (3)

Publication Number Publication Date
FI961720A FI961720A (fi) 1996-04-19
FI961720A0 FI961720A0 (fi) 1996-04-19
FI116931B true FI116931B (fi) 2006-04-13

Family

ID=26303736

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961720A FI116931B (fi) 1993-10-22 1996-04-19 Menetelmä farmaseuttisen tai eläinlääketieteellisen koostumuksen valmistamiseksi

Country Status (28)

Country Link
US (1) US6025389A (fr)
EP (1) EP0727979B1 (fr)
JP (1) JPH09506865A (fr)
KR (1) KR100374462B1 (fr)
CN (1) CN1102410C (fr)
AP (1) AP608A (fr)
AT (1) ATE202467T1 (fr)
AU (1) AU692486B2 (fr)
BG (1) BG62912B1 (fr)
BR (1) BR9407840A (fr)
CA (1) CA2174658C (fr)
CZ (1) CZ292223B6 (fr)
DE (1) DE69427589T2 (fr)
DK (1) DK0727979T3 (fr)
ES (1) ES2157996T3 (fr)
FI (1) FI116931B (fr)
GR (1) GR3036591T3 (fr)
HK (1) HK1012284A1 (fr)
HU (1) HU221853B1 (fr)
NO (1) NO313446B1 (fr)
NZ (1) NZ275282A (fr)
OA (1) OA10361A (fr)
PL (1) PL177592B1 (fr)
PT (1) PT727979E (fr)
RO (1) RO112987B1 (fr)
SK (1) SK280222B6 (fr)
UA (1) UA39896C2 (fr)
WO (1) WO1995010999A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
KR20000048812A (ko) * 1996-10-01 2000-07-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 병원성 유기체에 의한 비인두 전이증식 관련 세균 감염 치료용약제를 제조하기 위한 뮤피로신의 용도
EP1033969A1 (fr) * 1997-09-11 2000-09-13 Smithkline Beecham Plc Compositions adaptees pour un sejour prolonge dans le rhino-pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
JP2007502861A (ja) * 2003-05-01 2007-02-15 レプリダイン・インコーポレーテッド 抗菌方法及び組成物
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
WO2008007182A2 (fr) * 2006-07-07 2008-01-17 Glenmark Pharmaceuticals Limited Compositions pharmaceutiques topiques de mupirocine ou sels ou esters de qualité pharmaceutique de ces composés
BR112012024999A2 (pt) 2010-03-30 2016-07-12 Helperby Therapeutics Ltd combinação e uso
US8940723B2 (en) 2010-08-05 2015-01-27 Helperby Therapeutics Limited Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
CN103249402A (zh) 2010-10-08 2013-08-14 赫尔普百治疗有限公司 新组合物
DK2704704T3 (en) 2011-05-03 2019-01-14 Dupont Nutrition Biosci Aps PROBIOTIC BACTERIES FOR TOPICAL TREATMENT OF SKIN DISORDERS
GB201107755D0 (en) 2011-05-10 2011-06-22 Helperby Therapeutics Ltd Novel compounds
CN102335122B (zh) * 2011-06-21 2013-04-17 北京协和药厂 一种莫匹罗星软膏及其制备方法
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
CA2933081C (fr) 2013-12-17 2023-04-04 Hatchtech Pty Ltd. Composition pediculicide
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
JP6629327B2 (ja) 2014-12-18 2020-01-15 ヘルパービー セラピューティクス リミテッドＨｅｌｐｅｒｂｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ 微生物感染の予防または治療で使用される組み合わせ
WO2016133471A1 (fr) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. Composition topique contenant de la mupirocine et du dexpanthénol
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
JP2019513769A (ja) 2016-04-19 2019-05-30 ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ アトピー性皮膚炎を処置するためのグラム陰性種の使用
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201620095D0 (en) 2016-11-28 2017-01-11 Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And Novel use
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
WO2019141957A1 (fr) 2018-01-19 2019-07-25 Cado Biotechnology Ivs Dérivés d'hydroxy pyrazole n-pyrimidinyle et utilisations associées
US10973841B2 (en) 2018-05-11 2021-04-13 Forte Subsidiary, Inc. Compositions for the treatment of skin conditions
US10709663B2 (en) 2018-10-17 2020-07-14 Glenmark Pharmaceuticals, Inc., Usa Mupirocin cream in pump device
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
US20210299019A1 (en) * 2020-03-31 2021-09-30 Chemistryrx Methods for treating hyperpigmentation and compositions for same
BR112023020137A2 (pt) 2021-03-30 2023-11-28 Dupont Nutrition Biosci Aps Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions

Also Published As

Publication number Publication date
CA2174658A1 (fr) 1995-04-27
AU692486B2 (en) 1998-06-11
OA10361A (en) 2001-11-21
NZ275282A (en) 1996-10-28
AU8084794A (en) 1995-05-08
SK49596A3 (en) 1997-02-05
CN1102410C (zh) 2003-03-05
DE69427589T2 (de) 2002-04-25
AP9600798A0 (en) 1996-04-30
BG62912B1 (bg) 2000-11-30
DK0727979T3 (da) 2001-10-01
SK280222B6 (sk) 1999-10-08
KR100374462B1 (ko) 2003-06-09
CZ112096A3 (en) 1996-07-17
CA2174658C (fr) 2000-12-19
NO961588L (no) 1996-04-19
UA39896C2 (uk) 2001-07-16
EP0727979A4 (fr) 1996-11-27
WO1995010999A1 (fr) 1995-04-27
HK1012284A1 (en) 1999-07-30
HU9601030D0 (en) 1996-06-28
CN1135715A (zh) 1996-11-13
BG100501A (bg) 1996-12-31
GR3036591T3 (en) 2001-12-31
CZ292223B6 (cs) 2003-08-13
FI961720A (fi) 1996-04-19
HUT74510A (en) 1997-01-28
PT727979E (pt) 2001-11-30
NO961588D0 (no) 1996-04-19
US6025389A (en) 2000-02-15
DE69427589D1 (de) 2001-08-02
ES2157996T3 (es) 2001-09-01
HU221853B1 (hu) 2003-02-28
BR9407840A (pt) 1997-05-13
ATE202467T1 (de) 2001-07-15
RO112987B1 (ro) 1998-03-30
NO313446B1 (no) 2002-10-07
FI961720A0 (fi) 1996-04-19
PL177592B1 (pl) 1999-12-31
AP608A (en) 1997-08-28
PL314038A1 (en) 1996-08-05
JPH09506865A (ja) 1997-07-08
EP0727979B1 (fr) 2001-06-27
EP0727979A1 (fr) 1996-08-28

Similar Documents

Publication Publication Date Title
FI116931B (fi) Menetelmä farmaseuttisen tai eläinlääketieteellisen koostumuksen valmistamiseksi
US4818521A (en) Emulsion cosmetic stably containing vitamin C
US5990100A (en) Composition and method for treatment of psoriasis
US5143717A (en) Burn foam and delivery system
US9161916B2 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
KR20010031712A (ko) 유중수형 유화제 조성물
US20050123576A1 (en) Mupirocin compositions for topical use, an improved process of making same and methods of using same
KR20010032892A (ko) 비타민 ｄ３유도체를 함유하는 크림제
US20020143072A1 (en) Low turbidity microemulsions
CA1238276A (fr) Creme de dipropionate de betamethasone
US6124348A (en) Vitamin C skin formulations
JP2545317B2 (ja) 医薬製剤
JP2865867B2 (ja) ペンシクロビル含有の局所用組成物
RU2148998C1 (ru) Фармацевтическая или ветеринарная композиция (варианты) и способ получения композиции
JPH0366618A (ja) 薬学的配合物
JPS6333326A (ja) 抗菌剤組成物
KR20010032864A (ko) 비타민 ｄ3 유도체를 함유하는 로션제
JPH0692841A (ja) エアゾール組成物の製法
CZ269293A3 (en) Medicinal ointment without skin irritating effect and process for preparing thereof
CS239217B1 (cs) Masťový základ typu emulze voda/olej

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116931

Country of ref document: FI

MA Patent expired